Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer

被引:11
|
作者
Narukawa, Tsukasa [1 ]
Hara, Tomohiko [1 ]
Arai, Eri [2 ]
Komiyama, Motokiyo [1 ]
Kawahara, Takashi [1 ]
Kanai, Yae [2 ]
Fujimoto, Hiroyuki [1 ]
机构
[1] Natl Canc Ctr, Div Urol, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan
关键词
urology; urologic-med; upper urinary tract urothelial carcinoma; ureteral cancer; renal pelvic cancer; intravesical recurrence; TRANSITIONAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; CUMULATIVE INCIDENCE; COMPETING RISK; MODEL; MULTICENTER; PREVENTION; LOCATION; IMPACT; TRIALS;
D O I
10.1093/jjco/hyv019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Patients with upper urinary tract urothelial carcinoma (UUT-UC) without a history of bladder cancer have a different natural history of intravesical recurrence after nephroureterectomy compared with those with a history of bladder cancer. The aim of this study was to identify predictive factors for post-operative intravesical recurrence in patients with non-metastatic upper urinary tract-localized urothelial carcinoma without a history of bladder cancer and who were not taking medication during the perioperative period. Methods: This retrospective study included 133 patients who were treated between 1995 and 2012. Univariate and multivariate analyses were used to evaluate the clinical and pathological factors associated with the cumulative incidence of bladder cancer. Results: Of the 133 patients, 51 (38.3%) developed intravesical recurrence during a median follow-up of 71 months (range, 0.8-210.8). In the multivariate analysis, multifocality (P = 0.03) and high tumour grade (P = 0.007) were significantly associated with the cumulative incidence of bladder cancer. We constructed a prediction classification model on the basis of the total number of risk factors. The 2-year cumulative incidence rates were 5.6, 34.8 and 50.0% in individuals with no, one and two risk factors, respectively. There was a significant difference between patients with no risk factors and those with two risk factors (P = 0.01). Conclusions: Although this retrospective study had several limitations, tumour multifocality and tumour grade were found to be potential risk factors for intravesical recurrence in our cases.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 50 条
  • [1] Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer
    Sato, Goro
    Yoshida, Takashi
    Yanishi, Masaaki
    Saito, Ryoichi
    Murota, Takashi
    Kawa, Gen
    Kinoshita, Hidefumi
    Matsuda, Tadashi
    CLINICAL GENITOURINARY CANCER, 2020, 18 (02) : E167 - E173
  • [2] Preoperative monocyte-to-lymphocyte ratio for intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract after radical nephroureterectomy without a history of bladder cancer
    Liu, Jianyong
    Wu, Pengjie
    Lai, Shicong
    Song, Xinda
    Fu, Chunlong
    Wang, Xuan
    Liu, Shengjie
    Hou, Huimin
    Liu, Ming
    Wang, Jianye
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 : 63 - 63
  • [3] Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma
    Ryo Yamashita
    Reiko Watanabe
    Ichiro Ito
    Hideo Shinsaka
    Masafumi Nakamura
    Masato Matsuzaki
    Masashi Niwakawa
    International Urology and Nephrology, 2017, 49 : 425 - 430
  • [4] Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma
    Yamashita, Ryo
    Watanabe, Reiko
    Ito, Ichiro
    Shinsaka, Hideo
    Nakamura, Masafumi
    Matsuzaki, Masato
    Niwakawa, Masashi
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (03) : 425 - 430
  • [5] Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer
    Liu, Jianyong
    Wu, Pengjie
    Lai, Shicong
    Song, Xinda
    Fu, Chunlong
    Wang, Xuan
    Liu, Shengjie
    Hou, Huimin
    Liu, Ming
    Wang, Jianye
    CLINICAL GENITOURINARY CANCER, 2021, 19 (03) : E156 - E165
  • [6] Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract
    Ku, Ja Hyeon
    Choi, Woo Seok
    Kwak, Cheol
    Kim, Hyeon Hoe
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (04) : 383 - 387
  • [7] Intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma
    Ito, Akihiro
    Shintaku, Ichiro
    Satoh, Makoto
    Yamashita, Shinichi
    Arai, Yoichi
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (04) : 435 - 436
  • [8] INTRAVESICAL RECURRENCE AFTER NEPHROURETERECTOMY INFLUENCES OVERALL SURVIVAL OF UPPER URINARY TRACT UROTHELIAL CARCINOMA PATIENTS
    Yamashita, Shinichi
    Ito, Akihiro
    Shintaku, Ichiro
    Aizawa, Masataka
    Tochigi, Tatsuo
    Soma, Fumihiko
    Ota, Shozo
    Namima, Takashige
    Orikasa, Kazuhiko
    Kyan, Atsushi
    Numahata, Kenji
    Takeda, Atsushi
    Katoh, Shinnosuke
    Kaiho, Yasuhiro
    Nakagawa, Haruo
    Ioritani, Naomasa
    Arai, Yoichi
    JOURNAL OF UROLOGY, 2014, 191 (04): : E895 - E895
  • [9] THE IMPACT OF NEPHROURETERECTOMY WITH OR WITHOUT BLADDER CUFF EXCISION ON BLADDER RECURRENCE FOR PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA
    Yi-Shiou, T.
    Shiu-Dong, C.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 289 - 289
  • [10] The Impact of Nephroureterectomy with or without Bladder Cuff Excision for Patients with Upper Urinary Tract Urothelial Carcinoma on Bladder Recurrence
    Tseng, Y.
    Chung, S.
    UROLOGY, 2012, 80 (03) : S335 - S335